About
Investor Contact
Senior Director, Investor Relations & Business Development
ron.moldaver@cartesiantx.com
Media Contact
david.rosen@argotpartners.com
![](https://ml.globenewswire.com/media/ZjQ4NWMyODItZGUzMi00Yjc0LTkzMDgtZjJjZGNjZTRkY2E0LTEwNjE3MDA=/tiny/Cartesian-Therapeutics-Inc-.png)
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.76 USD | +4.96% |
|
+0.79% | -14.13% |
About
Investor Contact
Senior Director, Investor Relations & Business Development
ron.moldaver@cartesiantx.com
Media Contact
david.rosen@argotpartners.com
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-14.13% | 301M | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |